[Hepatic lesion in patients with hepatocerebral dystrophy]

Insights

Hepatocerebral dystrophy (HCD) presents varied liver damage, with hepatic and endocrine variants showing the most severe clinical, biochemical, and immune affections. Viral infections can worsen liver injury in HCD patients.

Area of Science:

  • Hepatology
  • Neurology
  • Genetics

Background:

  • Hepatocerebral dystrophy (HCD) is a rare genetic disorder affecting both the liver and brain.
  • Understanding the spectrum of hepatic involvement in HCD is crucial for patient management.

Purpose of the Study:

  • To investigate the clinical course and duration of hepatic affection in patients with hepatocerebral dystrophy.
  • To characterize the different variants of HCD based on clinical presentation and liver pathology.

Main Methods:

  • Retrospective analysis of 63 HCD patient records.
  • Evaluation of early clinical symptoms, disease onset, liver function tests, liver morphology, immune status, cytokine profiles, and viral hepatitis markers.

Main Results:

  • Six HCD variants identified: hepatic (24), endocrine (17), neurological (12), psychoemotional (5), hemolytic (3), and renal (1).
  • Hepatic variant showed progressive hepatitis and cirrhosis; others exhibited fibrosis, lipofuscinosis, and fatty liver disease.
  • Hepatotropic virus markers (Hepatitis B, C, G, TT) were more common in the hepatic variant. Mild inflammation indicated by elevated aminotransferases, immunoglobulins, and cytokines.

Conclusions:

  • Hepatic lesions in HCD are diverse, with the most severe clinical, biochemical, and immunological manifestations observed in hepatic and endocrine variants.
  • Neurological, psychoemotional, and hemolytic variants presented with less severe hepatic involvement.
  • Hepatotropic viral infections can exacerbate liver damage in HCD, which is primarily caused by copper imbalance.
Abstract

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...